Routinely used insulin sensitizers metformin and pioglitazone, improved the glucose utilization and dyslipidemia in iNOS-/- mice along with rescued circulating LDL which was not affected by NO sufficiency. The gene discussed is NOS2; the disease is metabolic syndrome.